Competitive Landscape

Home

Rilemo's technology is the only portable, real-time electromagnetic brain imaging solution capable of operating in any point-of-care setting.

To frame this positioning clearly, competitors can be divided into three categories:

companies working on electromagnetic brain imaging devices directly comparable to Rilemo

companies developing portable neuroimaging solutions using alternative technologies

traditional diagnostic modalities that define the current standard of care.

Competitors in electromagnetic imaging

The electromagnetic imaging landscape for brain applications consists of a small number of companies developing non-invasive microwave-based solutions. However, no existing company currently offers a device that combines true portability, real-time imaging, and bedside usability in a single system.

Company *	Nation	Bedside Imaging	Portability	Weight	Real-time Capabilities
Rilemo	🇮🇹 Italy	Yes	Pocket-sized	0.9 kg	Yes
EMVision	🇦🇺 Australia	Yes	Cart-mounted	12-50 kg	No
EMTensor	🇦🇹 Austria	Yes	Cart-mounted	~ 80 kg	No
UBTech	🇮🇹 Italy	No	Not portable	> 200 kg	No

* Research laboratories are not included in this table, a longer analysis is available on request

EMVision (ASX: EMV) is the most advanced electromagnetic competitor, currently conducting pivotal clinical trials. Its bedside emu™ device is not yet commercially available and has not received CE marking or FDA clearance. Guidance pricing is approximately US$175,000 per unit.

Further information on Rilemo's technical advantages over these competitors is available in the

Technology Overview section.

Portable neuroimaging - adjacent technologies

Beyond electromagnetic imaging, a growing category of portable brain imaging devices using alternative technologies is emerging. These solutions address the same clinical need, bedside neuroimaging without CT or MRI infrastructure, but through fundamentally different technological approaches with distinct trade-offs.

Hyperfine Swoop® (Nasdaq: HYPR) is the most commercially advanced player in this category. The Swoop system is an ultra-low-field portable MRI (0.064T) that is FDA cleared, CE marked, and commercially available across the United States and select European markets including Germany, France, and the United Kingdom. It sold 38 commercial systems in 2025 at an average selling price of approximately $360,000 per unit, generating revenue of ~$13.5M for the full year.

The commercial traction of Hyperfine validates the market for portable bedside neuroimaging. At the same time, the MRI technology approach entails structural constraints that Rilemo does not share:

ㅤ	Hyperfine Swoop®	Rilemo
Technology	Ultra-low-field MRI	Electromagnetic (microwave)
Weight	~70 kg	0.9 kg
Portability	Bedside, requires power outlet	Fully portable, battery-operated
Pre-hospital use	No	Yes
Ionising radiation	No	No
Price	~$360,000	€50,000 (base case)
Regulatory status	FDA cleared, CE marked	CE marking in progress
Shielded room required	No	No

Rilemo's significantly lower price point, true portability, and pre-hospital capability position it as a complementary and in many settings more accessible solution, particularly in ambulance, emergency, and resource-constrained environments where MRI infrastructure is not available.

Traditional diagnostic techniques

Traditional imaging modalities remain the standard of care for neurological diagnosis. These technologies have strong diagnostic qualities but present structural limitations that Rilemo is designed to address, particularly in time-sensitive and decentralised settings.

Technique	Time to Diagnostic Information*	Versatility	Invasiveness	Portability
Rilemo’s ERSI	< 30 seconds	Yes	No clothes removal	Yes
Ultrasound	< 2 minutes	No neurology, No bone penetration	Undressing, contact, pressure	Yes
X-Ray **	2 - 5 minutes	No	Undressing, no contact	On vehicle
CT Scan **	5 - 10 minutes	Yes	Undressing, no contact	No
MRI **	15 - 30 minutes	Yes	Undressing, no contact	No

* Considers the time took from the identification of the need to image the patient with the machine available near the patient, to the results being shown to the doctor. This therefore includes the patient preparation time.
** Needs a shielded room or physical separation from the subject and machine under operation, together with Personal Protective Equipment

Conclusion

Rilemo positions itself at the intersection of three unmet needs that no single existing solution currently addresses simultaneously: portability, real-time brain imaging, and accessibility across all care settings, inside and outside the hospital.

Electromagnetic competitors are not yet commercially available and remain constrained by size and weight. Portable MRI solutions validate the market but are structurally limited in price, portability, and pre-hospital applicability. Traditional modalities are indispensable but inaccessible at the point of care.

This competitive gap, confirmed by Rilemo's own clinical interview dataset and by the commercial emergence of adjacent technologies mentioned in section

Market Overview, defines the opportunity that Rilemo's technology is designed to capture.

Click here to go back to the Home

This Data Room is provided to you by:

Rilemo S.r.l.

Via Don Sebastiano Colleoni 20, Robbiate (LC), 23899, Italy

EU VAT: IT 04187140134 - ATECO: 26.60.02

PEC: rilemo@legalmail.it